ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in glioma
ARHGDIB emerges as a novel marker for tumor-associated macrophages, playing a crucial role in shaping the immunosuppressive microenvironment and representing a promising prognostic biomarker for glioma.
Authors
- Rongnian Li
- Xingjun Jiang (ORCID: https://orcid.org/0000-0002-9689-2669)
- Quanwei Zhou
- Xuejun Yan (ORCID: https://orcid.org/0000-0001-8635-2979)
- Jing Xu (ORCID: https://orcid.org/0000-0002-8688-2352)
- Hua Liu (ORCID: https://orcid.org/0000-0001-7729-1246)
- Caiping Ren (ORCID: https://orcid.org/0000-0001-6880-7394)
- Minmin He
Institutions
- Xiangyang Hospital of Traditional Chinese Medicine (CN)
- Hunan Provincial Maternal and Child Health Hospital (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1007/s00262-025-04063-7
- Citations
- 3
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.88
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Hunan Province
- Basic and Applied Basic Research Foundation of Guangdong Province